Andy Arno

Andrew Arno was the founder of Unterberg Capital LLC, founded in 2009, serving as Vice Chairman & Chief Marketing Officer from 2009 to 2012.
Current jobs include Chairman, CEO, CFO & Secretary at ComHear, Inc. since 2017; Independent Chairman at Insight Molecular Diagnostics, Inc. since 2022; Independent Director at Smith Micro Software, Inc. since 2011; Lead Independent Director at 22nd Century Group, Inc. since 2023; Director at Independa, Inc.; Treasurer & Director at The Jewish Community Center in Manhattan, Inc. since 2012; Director at New York Service for the Handicapped; and Independent Director at Catheter Precision, Inc. since 2024.
Former jobs include Chairman & Chief Executive Officer at C.
E.
Unterberg, Towbin Advisors LP; Chairman & Chief Executive Officer at C.
E.
Unterberg, Towbin, Inc. from 1990 to 2007; Chairman & Chief Executive Officer at Collins Stewart LLC from 2007 to 2008; Vice Chairman at Merriman Holdings, Inc. from 2009 to 2011; Vice Chairman & Head-Equity Capital Markets at Merriman Capital, Inc.; Vice Chairman at The Special Equities Group LLC from 2015 to 2023; Chairman at Collins Stewart LLC (Investment Management) from 2007 to 2008; Vice Chairman at Bradley Woods & Co. Ltd. from 2013 to 2015; Vice Chairman at Chardan Capital Markets LLC from 2015 to 2019; Managing Director at Emerging Growth Equities Ltd. from 2013 to 2015; Independent Director at Asterias Biotherapeutics, Inc. from 2014 to 2019; Managing Director-Emerging Growth Equities at Sabr Group, Inc. from 2013 to 2015; Vice President at Lehman Brothers, Inc. in 1989; President at Loewen, Ondaatje, McCutcheon USA Ltd.; Vice President-Individual Investors Services at L.
F.
Rothschild, Unterberg, Towbin, Inc. from 1981 to 1986; and President at Lomusa Ltd. in 2012.
Education includes undergraduate studies at George Washington University.